COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > Largest volume on NASDAQ since the close of the merger

<< Previous

Bullboard Posts

Next >>

Comment by tigerproon Jul 10, 2024 12:29am

85 Views

Post# 36125693

RE:RE:Largest volume on NASDAQ since the close of the merger

The CEO just wants to pump the stock price before shareholder meeting. Then he can be the board member and CEO forever.

He did this several times before. He did the same thing before the merge vote several month ago.

Old shareholders know this very well. New shareholders will be fooled again.

So the CEO wish old shareholders sell their shares to new guys. Then all problems solved.

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide